Skip to main content

Table 2 Grey literature reviewed in the scoping study, including the source and title

From: A scoping study to identify opportunities to advance the ethical implementation and scale-up of HIV treatment as prevention: priorities for empirical research

Year

Title

Document type

Source organization

Ethical issues emphasized

Setting

2013

Mapping pathways: Developing evidence-based, people-centred strategies for the use of antiretrovirals as prevention

Report

Rand Website

C

Worldwide

2012

Treatment as Prevention: recognising the creative potential of antiretroviral medications

Online article

HIV, Science, and the Social

A, B

Worldwide

2013

Reactions to the test-and-treat models

Online article

NAM AIDS MAP

A, C

Worldwide

2012

Emerging Issues in Today’s HIV Response: Debate 6 Treatment as Prevention

Report

AIDSTAR-One

B, C

Worldwide

2013

The Human Rights Issue

Online article

NAM AIDS MAP

A, B

Worldwide

2010

Treatment as Prevention: Protecting Individual Autonomy

Online article

aidsperspective.net

A, B

Worldwide

2009

Ethics of ART for HIV Prevention as a Public Health Intervention

Presentation

WHO

A, B, C

Worldwide

2009

Consultation on Antiretroviral Treatment for Prevention of HIV Transmission: Meeting Report

Report

WHO

B, C

Worldwide

2013

Changing my mind on treatment as prevention

Online article

Positive Lite

A, C

Worldwide

2010

Prominent Parisian Activist Weighs in on Treatment as Prevention

Online article

POZ Blogs

A

Worldwide

2010

Views from the front lines: Treatment as Prevention

Online article

CATIE

B, C

Canada

2013

Treatment as prevention: Bob Leahy in conversation with James Wilton

Online article

CATIE

A, C

Canada

2012

Treatment benefits for all?

Online article

CATIE

A, B

Canada

2009

Antriretroviral treatment for prevention

Position statement

UN AIDS

A

Worldwide

2012

Controlling the HIV Pandemic with Antiretrovirals: Treatment as Prevention and Pre-Exposure Prophylaxis - Consensus Statement

Position statement

IAPAC

A, B, C

Worldwide

2013

The use of antiretroviral therapy to reduce HIV transmission

Position statement

BHIVA, EAGA

C

Worldwide

2010

Biomedical Prevention Is Always About Social Justice, Too

Online article

HIV Research Catalyst Forum

A

Worldwide

2010

USPHS guidelines: We need reliable evidence to justify an earlier start of anti-retroviral therapy

Online article

aidsperspective.net

C

Worldwide

2011

Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention

Presentation

CATIE

A

Worldwide

  1. A = Balancing individual- and population-level interests.
  2. B = Power relations within clinical practice and competing resource demands within health care systems.
  3. C = Effectiveness considerations and socio-structural contexts of HIV-related experience.